Patent · US Expired

Method for producing a pharmaceutical composition comprising rotigotine

US8604076B2 · kind B2 · utility

2Cited by

44References

9Claims

0Family size

Assignee

UCB Pharma GMBH · DE

Inventors

Stephan Rimpler · Hilden, DE
Sabine Grapatin · Langenfeld, DE
Cliff Krein · Overath, DE
Markus Thelen · Monheim, DE

Key dates

Filing date	Aug 21, 2001
Grant date	Dec 10, 2013
Priority date	—
Expiry date	Aug 14, 2024

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions are provided for administration of rotigotine in depot form. Pharmaceutical compositions of the invention can provide therapeutically significant plasma levels of rotigotine over a period of at least 24 hours after administration to a patient. Preferred pharmaceutical compositions of the invention include oily suspensions that contain rotigotine in solid form as well as anhydrous pharmaceutical compositions that comprise rotigotine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.